MacuCLEAR
Pioneering innovative treatments for vascular eye disorders with promising clinical success.
Pioneering innovative treatments for vascular eye disorders with promising clinical success.
MacuCLEAR is a pioneering clinical-stage pharmaceutical company founded in 2006 that specializes in developing innovative treatments for vascular eye disorders. With the slogan "Pioneering innovative treatments for vascular eye disorders with promising clinical success," MacuCLEAR aims to revolutionize the biotechnology, health care, and pharmaceutical industries. The company holds an active IND for MC-1101 and has successfully completed a Phase Ib/POC human clinical trial, showcasing promising progress in its research and development. The last recorded investment for MacuCLEAR was a $1.00M Venture Round investment on 03 January 2012, signifying investor confidence in the company's potential.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $1.00M | - | 03 Jan 2012 |
No recent news or press coverage available for MacuCLEAR.
We care about your data, and we'd love to use cookies make your experience better.
